Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Adventitial Histopathology in Borderline Ascending Aortic Dilatatio Study completion date changed from estimate of Sep 1, 2025 to Jun 30, 2026
- Notable: Butyrate Effect on Diarrhea Primary completion date changed from estimate of Dec 31, 2025 to Oct 30, 2026
- Notable: Lokomat-Robot Assisted Gait Training on Gross Motor Function in Children and Young · Cerebral Palsy Start date pushed from Aug 31, 2026 to Jan 31, 2027
- Notable: TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention Primary completion moved earlier from Feb 17, 2040 to Oct 2036
- Notable: Virtual Outreach and Individualized Coaching Extension Start date pushed from Oct 2026 to Dec 2026
- Notable: Understanding How Peer Support Helps in Mental Health Care Start date pushed from Sep 2026 to Nov 2026
- Notable: Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation Start date pushed from Jan 15, 2027 to Mar 15, 2027
- Notable: Forging New Paths: Building Interventions · Criminogenic Needs in Community Based Mental Health Settings Results posted: Nov 18, 2026
- Notable: Nectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors Enrollment increased: 20 → 40 participants
- Notable: AI-enabled Communication to Advance Research Engagement (AI-CARE) Start date pushed from Oct 1, 2026 to Jan 15, 2027
- Notable: MyStroke for Stroke Survivors and Caregivers Start date pushed from Nov 1, 2026 to Dec 1, 2026
- Notable: Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum Primary completion date changed from estimate of May 30, 2025 to Dec 31, 2025
- Notable: Culturally Adapted Motivational Interviewing With CBT and Mindfulness Based Relapse Prevention for Substance Use Disorder in Pakistan (CAMIAB) Primary completion date changed from estimate of Jun 2025 to Jun 20, 2026
- Notable: Collection of Venous and Capillary Blood Samples Research, Optimization and Calibration of New Diagnostic Devices Enrollment reduced: 30000 → 12000 participants
- Notable: PDS Versus NACT-IDS in AI-Selected Advanced Epithelial Ovarian Cancer Enrollment reduced: 534 → 130 participants
- Notable: Opioid-Free Anesthesia in Colorectal Surgery, 2025 (OFA-CRC-2025) Enrollment reduced: 200 → 100 participants
- Notable: Intravenous Versus Oral Treatment of the Main Acute Infections Enrollment reduced: 4000 → 2640 participants
- Notable: Community Study to Increase Mammogram Screening Among Overdue Women Enrollment reduced: 15000 → 1500 participants
- Notable: Intensive Weight Loss Intervention Versus Bariatric Surgery · Severe and Complex Obesity: the LightBAR Randomised Trial Enrollment reduced: 500 → 316 participants
- Notable: Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study Enrollment reduced: 400 → 240 participants
- Notable: 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream · Lichen Sclerosus Primary endpoint(s) modified
- Notable: Garetosmab Versus Placebo Administered Intravenously (IV) · Fibrodysplasia Ossificans Progressiva (FOP) Results posted: Nov 17, 2026
- Notable: Orally Administered JBI-802 · Essential Thrombocythemia (ET) and Polycythemia Vera (PV) With Thrombocytosis Primary and study completion dates pushed to Jan 30, 2031
- Notable: Trials of SHR-8203 Injection · Advanced Solid Tumors Recruitment opened
- Notable: HER3-DXd · Locally Advanced or Metastatic Solid Tumors Primary completion pushed from Sep 1, 2027 to Nov 19, 2030
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates